Truist Securities Maintains Buy on Inspire Medical Systems, Raises Price Target to $380
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Richard Newitter maintains a 'Buy' rating on Inspire Medical Systems (NYSE:INSP) and raises the price target from $360 to $380.
July 19, 2023 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a 'Buy' rating on Inspire Medical Systems and raises the price target from $360 to $380. This could potentially lead to an increase in the stock price.
The 'Buy' rating maintained by Truist Securities and the increase in price target from $360 to $380 indicates a positive outlook for Inspire Medical Systems. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100